Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$524M |
| 2 |
Meta Platforms (Facebook)
META
|
+$458M |
| 3 |
Otis Worldwide
OTIS
|
+$345M |
| 4 |
T-Mobile US
TMUS
|
+$307M |
| 5 |
AbbVie
ABBV
|
+$280M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$878M |
| 2 |
RTN
Raytheon Company
RTN
|
+$537M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$435M |
| 4 |
Apple
AAPL
|
+$389M |
| 5 |
Accenture
ACN
|
+$216M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.72% |
| 2 | Healthcare | 14.52% |
| 3 | Financials | 12.98% |
| 4 | Consumer Discretionary | 10.98% |
| 5 | Communication Services | 9.74% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
COOP
1726
DELISTED
Mr. Cooper
COOP
| $14.1M | ﹤0.01% |
1,132,708
+9,968
| +0.9% | +$99.9K |
|
|
FARO
1727
DELISTED
Faro Technologies
FARO
| $14.1M | ﹤0.01% |
262,688
+12,658
| +5% | +$663K |
|
|
INFN
1728
DELISTED
Infinera Corporation Common Stock
INFN
| $14M | ﹤0.01% |
2,368,450
-82,149
| -3% | -$450K |
|
|
PRMW
1729
DELISTED
Primo Water Corporation
PRMW
| $14M | ﹤0.01% |
1,019,543
+994,401
| +3,955% | +$11.2M |
|
|
RAD
1730
DELISTED
Rite Aid Corporation
RAD
| $14M | ﹤0.01% |
821,214
+59,306
| +8% | +$799K |
|
|
FOE
1731
DELISTED
Ferro Corporation
FOE
| $14M | ﹤0.01% |
1,169,975
+30,587
| +3% | +$329K |
|
1732
United Natural Foods
UNFI
$2.9B
| $14M | ﹤0.01% |
766,794
+27,160
| +4% | +$407K |
|
|
SAFE
1733
Safehold
SAFE
$1.13B
| $13.9M | ﹤0.01% |
232,509
+36,488
| +19% | +$1.84M |
|
|
EVOP
1734
DELISTED
EVO Payments, Inc. Class A Common Stock
EVOP
| $13.9M | ﹤0.01% |
610,228
+20,380
| +3% | +$405K |
|
1735
Matador Resources
MTDR
$6.04B
| $13.9M | ﹤0.01% |
1,634,084
+46,414
| +3% | +$324K |
|
|
EGIO
1736
DELISTED
Edgio, Inc. Common Stock
EGIO
| $13.9M | ﹤0.01% |
47,079
+5,320
| +13% | +$1.18M |
|
1737
Infosys
INFY
$50.1B
| $13.8M | ﹤0.01% |
1,436,478
+569,210
| +66% | +$5.08M |
|
|
UCTT
1738
Ultra Clean Holdings
UCTT
$3.76B
| $13.8M | ﹤0.01% |
610,679
+3,445
| +0.6% | +$65.5K |
|
1739
OneSpan
OSPN
$598M
| $13.8M | ﹤0.01% |
493,685
+14,061
| +3% | +$276K |
|
1740
Intellia Therapeutics
NTLA
$1.57B
| $13.8M | ﹤0.01% |
655,355
+64,314
| +11% | +$1.09M |
|
1741
S&T Bancorp
STBA
$1.82B
| $13.8M | ﹤0.01% |
587,120
+12,494
| +2% | +$303K |
|
1742
Cactus
WHD
$5.5B
| $13.7M | ﹤0.01% |
666,456
+5,863
| +0.9% | +$102K |
|
|
SILK
1743
DELISTED
Silk Road Medical, Inc. Common Stock
SILK
| $13.7M | ﹤0.01% |
327,642
+154,766
| +90% | +$5.94M |
|
1744
Repay Holdings
RPAY
$330M
| $13.7M | ﹤0.01% |
556,944
+298,631
| +116% | +$6.02M |
|
|
GCP
1745
DELISTED
GCP Applied Technologies Inc.
GCP
| $13.7M | ﹤0.01% |
737,148
-8,357
| -1% | -$150K |
|
1746
Brown-Forman Class A
BF.A
$13.1B
| $13.7M | ﹤0.01% |
237,695
+12,269
| +5% | +$716K |
|
1747
Arcus Biosciences
RCUS
$3.56B
| $13.7M | ﹤0.01% |
552,689
+112,048
| +25% | +$3.02M |
|
1748
Southside Bancshares
SBSI
$974M
| $13.6M | ﹤0.01% |
491,997
-16,986
| -3% | -$482K |
|
1749
Travere Therapeutics
TVTX
$5.89B
| $13.6M | ﹤0.01% |
667,660
+7,729
| +1% | +$123K |
|
1750
Enerpac Tool Group
EPAC
$1.92B
| $13.6M | ﹤0.01% |
773,316
+20,657
| +3% | +$349K |
|
Similar funds
Geode Capital Management's Q2 2020 Portfolio in Review
As of Q2 2020, Geode Capital Management held 4,219 positions worth $467B, up 22% from $384B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Geode Capital Management's Q2 2020 filing shows 118 new, 2,550 increased, 1,055 reduced and 119 closed positions. Its largest new stake was Otis Worldwide: 6,650,358 shares worth $377M. The largest sale was Allergan plc, an estimated $878M.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 22% a quarter earlier, followed by Healthcare and Financials.
- Geode Capital Management's largest Q2 2020 buy was Otis Worldwide: 6,650,358 shares worth $377M.
- Geode Capital Management added most to Amazon in Q2 2020, an estimated $524M increase.
- Geode Capital Management's biggest Q2 2020 reduction was Bristol-Myers Squibb, cutting an estimated $435M.
- Geode Capital Management fully exited Allergan plc in Q2 2020, selling an estimated $878M.
- Geode Capital Management's ten largest holdings make up 23% of its $467B portfolio in Q2 2020.
- Geode Capital Management opened 118 new positions and closed 119 in Q2 2020.
- Geode Capital Management's portfolio value rose 22% quarter-over-quarter to $467B.
Based on Geode Capital Management's 13F filing for Q2 2020, filed 13 Aug 2020.